Veracyte develops and delivers molecular diagnostic tests that provide genomic insights to help clinicians make informed decisions for patients with cancer. The company operates facilities in South San Francisco, California and Austin, Texas, serving a global patient population.
The company's diagnostic portfolio spans multiple cancer types, including thyroid, prostate, bladder, breast, and lung cancers. Each test is designed to support clinical decision-making and inform treatment pathways. Veracyte's stated goals include helping patients avoid unnecessary invasive procedures and accelerating access to appropriate treatment.
The team comprises scientists, engineers, and healthcare professionals working across genomic analysis, molecular diagnostics, precision medicine, and clinical laboratory services. The company emphasises a purpose-driven workplace centred on improving patient outcomes, with stated values around pursuing bold ideas, executing with urgency and excellence, and fostering collaboration grounded in integrity and respect.
